β2-Microglobulin modified with advanced glycation end products delays monocyte apoptosis
- 31 March 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (3) , 990-1002
- https://doi.org/10.1046/j.1523-1755.2001.059003990.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblastsKidney International, 1998
- Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)Cytometry, 1997
- Recognition of apoptotic cells by phagocytesCellular and Molecular Life Sciences, 1996
- Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end productsKidney International, 1996
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated AmyloidosisBiochemical and Biophysical Research Communications, 1994
- ApoptosisImmunology Today, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis.Annals of the Rheumatic Diseases, 1992
- Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis.Journal of Clinical Pathology, 1987